SG Americas Securities LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

SG Americas Securities LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 21,262 shares of the company's stock, valued at approximately $743,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the 4th quarter valued at $26,000. Signaturefd LLC boosted its position in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC boosted its position in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares during the period. Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after acquiring an additional 332 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Option Care Health during the fourth quarter valued at approximately $47,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Down 0.1%

Shares of NASDAQ:OPCH opened at $31.53 on Friday. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company's 50-day moving average price is $32.08 and its two-hundred day moving average price is $30.53. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82. The firm has a market cap of $5.16 billion, a P/E ratio of 25.43, a P/E/G ratio of 1.91 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The company's revenue was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.26 EPS. As a group, research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research report on Wednesday. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.